Nevertheless, systemic pharmacologic inhibition of ATX, both with small molecules and DNA aptamers, decreased LPA levels, and attenuated pulmonary fibrosis (49, 137, 138). The gene discussed is ENPP2; the disease is pulmonary fibrosis.